I absolutely agree. I have been in one OTC that did name / ticker change and RS at the same time, and it worked out fine, I made money and got out about two months after the name change with a profit. There was an initial "sugar-rush" from the event, and the price went up ~500%, and then it started to slowly come down and settle at some value, but it was still worth more than before the split and ticker change.
If they just do name / ticker change, and leave the SS as is, we could see a (possibly) higher percentage change, but it won't last long with this SS and would come right back down to where it is now (eventually). And everyone would still be afraid of a random RS at some point.
The worst possible thing they could do is a RS now, and then a name / ticker change later. That would just hurt all the existing shareholders.
And yes, they MUST reverse the AS as well. I was in a company that only did the OS, and it crashed the price down because it was obvious they intended to dilute. Eventually that company did reduce the AS, but it was too late by then.